BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu ZJ, Wu JJ, Jiang WL, Xiao JH, Tao KZ, Ma L, Zheng P, Wan R, Wang XP. MicroRNA-155 promotes the pathogenesis of experimental colitis by repressing SHIP-1 expression. World J Gastroenterol 2017; 23(6): 976-985 [PMID: 28246471 DOI: 10.3748/wjg.v23.i6.976] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 33] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Qin Q, Wang Y, Huang X, Jin X. SHIP-1 affects herpetic simplex keratitis prognosis by mediating CD4+ T lymphocytes migration through PI3K signaling and transcription factor KLF2 in the cornea. Antiviral Res 2022;:105424. [PMID: 36155071 DOI: 10.1016/j.antiviral.2022.105424] [Reference Citation Analysis]
2 Xin J. Critical signaling pathways governing colitis-associated colorectal cancer: Signaling, therapeutic implications, and challenges. Dig Liver Dis 2022:S1590-8658(22)00631-4. [PMID: 36002360 DOI: 10.1016/j.dld.2022.08.012] [Reference Citation Analysis]
3 Masi L, Capobianco I, Magrì C, Marafini I, Petito V, Scaldaferri F. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer. IJMS 2022;23:7991. [DOI: 10.3390/ijms23147991] [Reference Citation Analysis]
4 Li B, Guo L, He Y, Tu X, Zhong J, Guan H, Jiang Y, Jiang Q. MicroRNA-155 expression is associated with pulpitis progression by targeting SHIP1. Mol Biol Rep 2022. [PMID: 35834034 DOI: 10.1007/s11033-022-07690-w] [Reference Citation Analysis]
5 Innocenti T, Bigagli E, Lynch EN, Galli A, Dragoni G. MiRNA-Based Therapies for the Treatment of Inflammatory Bowel Disease: What Are We Still Missing? Inflamm Bowel Dis 2022:izac122. [PMID: 35749310 DOI: 10.1093/ibd/izac122] [Reference Citation Analysis]
6 Grillo TG, Quaglio AEV, Beraldo RF, Lima TB, Baima JP, Di Stasi LC, Sassaki LY. MicroRNA expression in inflammatory bowel disease-associated colorectal cancer. World J Gastrointest Oncol 2021; 13(9): 995-1016 [PMID: 34616508 DOI: 10.4251/wjgo.v13.i9.995] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
7 Guo J, Liao M, Wang J. TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155. Cell Commun Signal 2021;19:90. [PMID: 34479599 DOI: 10.1186/s12964-021-00771-6] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Amerikanou C, Papada E, Gioxari A, Smyrnioudis I, Kleftaki SA, Valsamidou E, Bruns V, Banerjee R, Trivella MG, Milic N, Medić-Stojanoska M, Gastaldelli A, Kannt A, Dedoussis GV, Kaliora AC; MAST4HEALTH. Mastiha has efficacy in immune-mediated inflammatory diseases through a microRNA-155 Th17 dependent action. Pharmacol Res 2021;171:105753. [PMID: 34224858 DOI: 10.1016/j.phrs.2021.105753] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Bocchetti M, Ferraro MG, Ricciardiello F, Ottaiano A, Luce A, Cossu AM, Scrima M, Leung WY, Abate M, Stiuso P, Caraglia M, Zappavigna S, Yau TO. The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer. Int J Mol Sci 2021;22:3967. [PMID: 33921348 DOI: 10.3390/ijms22083967] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
10 Malham M, James JP, Jakobsen C, Hoegdall E, Holmstroem K, Wewer V, Nielsen BS, Riis LB. Mucosal microRNAs relate to age and severity of disease in ulcerative colitis. Aging (Albany NY) 2021;13:6359-74. [PMID: 33647883 DOI: 10.18632/aging.202715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Diaz-Garrido N, Cordero C, Olivo-Martinez Y, Badia J, Baldomà L. Cell-to-Cell Communication by Host-Released Extracellular Vesicles in the Gut: Implications in Health and Disease. Int J Mol Sci 2021;22:2213. [PMID: 33672304 DOI: 10.3390/ijms22042213] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
12 Battistini C, Ballan R, Herkenhoff ME, Saad SMI, Sun J. Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases. Int J Mol Sci 2020;22:E362. [PMID: 33396382 DOI: 10.3390/ijms22010362] [Cited by in Crossref: 8] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
13 James JP, Riis LB, Malham M, Høgdall E, Langholz E, Nielsen BS. MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer. Int J Mol Sci 2020;21:E7893. [PMID: 33114313 DOI: 10.3390/ijms21217893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
14 Shi J, Chen M, Ouyang L, Wang Q, Guo Y, Huang L, Jiang S. miR-142-5p and miR-130a-3p regulate pulmonary macrophage polarization and asthma airway remodeling. Immunol Cell Biol 2020;98:715-25. [PMID: 32524675 DOI: 10.1111/imcb.12369] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
15 Pasca S, Jurj A, Petrushev B, Tomuleasa C, Matei D. MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases. Front Immunol 2020;11:625. [PMID: 32351507 DOI: 10.3389/fimmu.2020.00625] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
16 De Smet EG, Van Eeckhoutte HP, Avila Cobos F, Blomme E, Verhamme FM, Provoost S, Verleden SE, Venken K, Maes T, Joos GF, Mestdagh P, Brusselle GG, Bracke KR. The role of miR-155 in cigarette smoke-induced pulmonary inflammation and COPD. Mucosal Immunol 2020;13:423-36. [DOI: 10.1038/s41385-019-0241-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
17 Zeng Z, Mukherjee A, Zhang H. From Genetics to Epigenetics, Roles of Epigenetics in Inflammatory Bowel Disease. Front Genet. 2019;10:1017. [PMID: 31737035 DOI: 10.3389/fgene.2019.01017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
18 Pergande MR, Cougnoux A, Rathnayake RAC, Porter FD, Cologna SM. Differential Proteomics Reveals miR-155 as a Novel Indicator of Liver and Spleen Pathology in the Symptomatic Niemann-Pick Disease, Type C1 Mouse Model. Molecules 2019;24:E994. [PMID: 30870990 DOI: 10.3390/molecules24050994] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
19 Hibbs ML, Raftery AL, Tsantikos E. Regulation of hematopoietic cell signaling by SHIP-1 inositol phosphatase: growth factors and beyond. Growth Factors 2019;36:213-31. [DOI: 10.1080/08977194.2019.1569649] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Qu S, Shen Y, Wang M, Wang X, Yang Y. Suppression of miR-21 and miR-155 of macrophage by cinnamaldehyde ameliorates ulcerative colitis. Int Immunopharmacol 2019;67:22-34. [PMID: 30530166 DOI: 10.1016/j.intimp.2018.11.045] [Cited by in Crossref: 17] [Cited by in F6Publishing: 30] [Article Influence: 4.3] [Reference Citation Analysis]
21 Maneechotesuwan K. Role of microRNA in severe asthma. Respir Investig 2019;57:9-19. [PMID: 30455067 DOI: 10.1016/j.resinv.2018.10.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
22 Moein S, Vaghari-Tabari M, Qujeq D, Majidinia M, Nabavi SM, Yousefi B. MiRNAs and inflammatory bowel disease: An interesting new story. J Cell Physiol 2019;234:3277-93. [PMID: 30417350 DOI: 10.1002/jcp.27173] [Cited by in Crossref: 21] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
23 Garcia LE, de Araújo Junior EC, Melo LM, Bragato JP, Peiró JR, Félix de Lima VM, Marinho M, Arnold DR, Lopes FL. Characterization of the microtranscriptome of macrophages infected with virulent, attenuated and saprophyte strains of Leptospira spp. PLoS Negl Trop Dis 2018;12:e0006621. [PMID: 29979677 DOI: 10.1371/journal.pntd.0006621] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
24 Wang S, Huang Y, Zhou C, Wu H, Zhao J, Wu L, Zhao M, Zhang F, Liu H. The Role of Autophagy and Related MicroRNAs in Inflammatory Bowel Disease. Gastroenterol Res Pract 2018;2018:7565076. [PMID: 30046303 DOI: 10.1155/2018/7565076] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
25 Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, Vezza T, Utrilla MP, Chueca N, Fernández-Caballero JA, García F, Rodríguez-Cabezas ME, Gálvez J. The Administration of Escherichia coli Nissle 1917 Ameliorates Development of DSS-Induced Colitis in Mice. Front Pharmacol 2018;9:468. [PMID: 29867475 DOI: 10.3389/fphar.2018.00468] [Cited by in Crossref: 27] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
26 Nejad C, Stunden HJ, Gantier MP. A guide to miRNAs in inflammation and innate immune responses. FEBS J 2018;285:3695-716. [DOI: 10.1111/febs.14482] [Cited by in Crossref: 58] [Cited by in F6Publishing: 77] [Article Influence: 14.5] [Reference Citation Analysis]
27 Johansson K, Weidner J, Rådinger M. MicroRNAs in type 2 immunity. Cancer Lett 2018;425:116-24. [PMID: 29604393 DOI: 10.1016/j.canlet.2018.03.036] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
28 Dobranowski P, Sly LM. SHIP negatively regulates type II immune responses in mast cells and macrophages. J Leukoc Biol 2018. [PMID: 29345374 DOI: 10.1002/JLB.3MIR0817-340R] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
29 Soroosh A, Koutsioumpa M, Pothoulakis C, Iliopoulos D. Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2018;314:G256-62. [PMID: 29146677 DOI: 10.1152/ajpgi.00268.2017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 6.4] [Reference Citation Analysis]
30 Saradna A, Do DC, Kumar S, Fu QL, Gao P. Macrophage polarization and allergic asthma. Transl Res 2018;191:1-14. [PMID: 29066321 DOI: 10.1016/j.trsl.2017.09.002] [Cited by in Crossref: 86] [Cited by in F6Publishing: 125] [Article Influence: 17.2] [Reference Citation Analysis]
31 Alexandrov PN, Percy ME, Lukiw WJ. Chromosome 21-Encoded microRNAs (mRNAs): Impact on Down's Syndrome and Trisomy-21 Linked Disease. Cell Mol Neurobiol 2018;38:769-74. [PMID: 28687876 DOI: 10.1007/s10571-017-0514-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
32 Floch P, Capdevielle C, Staedel C, Izotte J, Sifré E, Laur AM, Giese A, Korolik V, Dubus P, Mégraud F, Lehours P. Deregulation of MicroRNAs in Gastric Lymphomagenesis Induced in the d3Tx Mouse Model of Helicobacter pylori Infection. Front Cell Infect Microbiol 2017;7:185. [PMID: 28560185 DOI: 10.3389/fcimb.2017.00185] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
33 Zhou D, Yang K, Chen L, Zhang W, Xu Z, Zuo J, Jiang H, Luan J. Promising landscape for regulating macrophage polarization: epigenetic viewpoint. Oncotarget 2017;8:57693-706. [PMID: 28915705 DOI: 10.18632/oncotarget.17027] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]